Which tool is commonly used to assess risk of bias in non-randomized studies?

Which tool is commonly used to assess risk of bias in non-randomized studies?

• A. ROBINS-I for non-randomized studies
• B. RoB 2 for randomized trials
• C. Cochrane risk of bias tool
• D. Jadad scale

Answer: (A)

When evaluating studies that aren’t randomized, you want a tool that specifically captures biases typical of observational designs. ROBINS-I, which stands for Risk Of Bias In Non-randomized Studies of Interventions, is designed for this purpose. It guides you through several bias domains that commonly affect non-randomized evidence: confounding (differences between groups that could influence outcomes), how participants and interventions are classified, deviations from planned interventions, missing data, how outcomes are measured, and how results are selected for reporting. The idea is to judge each domain and then form an overall risk of bias assessment that reflects how much the study’s results might be distorted compared with a ideal randomized trial. RoB 2 is aimed at randomized trials, not non-randomized studies, so it isn’t the right fit for observational evidence. The Cochrane risk of bias tool is typically associated with randomized trials as well (with newer versions focusing on randomized designs). The Jadad scale is an older, simpler measure that emphasizes only a few items like randomization, blinding, and withdrawals, which doesn’t adequately capture the breadth of bias issues in non-randomized research.

When evaluating studies that aren’t randomized, you want a tool that specifically captures biases typical of observational designs. ROBINS-I, which stands for Risk Of Bias In Non-randomized Studies of Interventions, is designed for this purpose. It guides you through several bias domains that commonly affect non-randomized evidence: confounding (differences between groups that could influence outcomes), how participants and interventions are classified, deviations from planned interventions, missing data, how outcomes are measured, and how results are selected for reporting. The idea is to judge each domain and then form an overall risk of bias assessment that reflects how much the study’s results might be distorted compared with a ideal randomized trial.

RoB 2 is aimed at randomized trials, not non-randomized studies, so it isn’t the right fit for observational evidence. The Cochrane risk of bias tool is typically associated with randomized trials as well (with newer versions focusing on randomized designs). The Jadad scale is an older, simpler measure that emphasizes only a few items like randomization, blinding, and withdrawals, which doesn’t adequately capture the breadth of bias issues in non-randomized research.